Landos Biopharma, Inc.

NASDAQ:LABP

22.93 (USD) • At close May 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 29.05437.54942.40844.04945.24436.6428.8819.24111.2888.30517.89318.6878.5722.4162.4779.808
Short Term Investments 000.0620.6874.7627.76219.11136.5162.50882.57584.77796.4497.78625.71832.85440.157
Cash and Short Term Investments 29.05437.54942.4744.73650.00644.40247.99155.75173.79690.88102.67115.127106.35828.13435.33149.965
Net Receivables 00000000000.0030.0020.0010.1540.1130.001
Inventory 00000000000001.39800
Other Current Assets 0.8420.4910.711.5491.1780.8511.4972.2873.5631.2661.6452.5983.3860.2020.1330.144
Total Current Assets 29.89638.0443.2346.28551.18445.25349.48858.03877.35992.146104.318117.727109.74529.88835.57750.11
Non-Current Assets:
Property, Plant & Equipment, Net 000000000.2240.7070.780.5640.4650.4440.3480.359
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 0000000000000000
Tax Assets 0000000000000000
Other Non-Current Assets 000000000.0270.02600000.8370.011
Total Non-Current Assets 000000000.2510.7330.780.5640.4650.4441.1850.37
Total Assets 29.89638.0443.2346.28551.18445.25349.48858.03877.6192.879105.098118.291110.2130.33236.76250.48
Liabilities & Equity:
Current Liabilities:
Account Payables 1.5651.3751.1351.0292.2983.4353.2044.7119.80312.90810.11410.6858.28.6066.6522.048
Short Term Debt 000000000.0270000000
Tax Payables 0000000000000000
Deferred Revenue 0000000000000000
Other Current Liabilities 5.1774.8744.4311.9861.8622.6872.2711.7995.6773.7030.9811.8450.6192.4281.3070.978
Total Current Liabilities 6.7426.2495.5663.0154.166.1225.4756.5115.50716.61111.09512.538.81911.0347.9593.026
Non-Current Liabilities:
Long Term Debt 0000000000000000
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities 00002.2983.4353.2044.7119.8312.9080.0850.1490.21273.31373.03773.037
Total Non-Current Liabilities 00002.2983.4353.2044.7119.8312.9080.0850.1490.21273.31373.03773.037
Total Liabilities 6.7426.2495.5663.0154.166.1225.4756.5115.50716.61111.1812.6799.03184.34780.99676.063
Equity:
Preferred Stock 0000000000105.098118.291110.2155.72900
Common Stock 0.0310.0310.0310.0310.3120.4030.4030.4030.4030.4030.4010.3990.3990.0710.0670.063
Retained Earnings -164.259-155.362-149.243-143.383-139.461-133.427-128.195-120.299-109.015-94.151-74.054-61.45-65.547-55.729-44.388-25.585
Accumulated Other Comprehensive Income/Loss 00-0.001-0.0070.079-0.057-0.211-0.392-0.467-0.2250.131-0.142-0.1020.010.036-0.077
Other Total Stockholders Equity 187.382187.122186.877186.629186.094172.212172.016171.816171.182170.24162.34248.51456.219-54.0960.0510.016
Total Shareholders Equity 23.15431.79137.66443.2747.02439.13144.01351.52862.10376.26893.918105.612101.179-54.015-44.234-25.583
Total Equity 23.15431.79137.66443.2747.02439.13144.01351.52862.10376.26893.918105.612101.179-54.015-44.234-25.583
Total Liabilities & Shareholders Equity 29.89638.0443.2346.28551.18445.25349.48858.03877.6192.879105.098118.291110.2130.33236.76250.48